Waycross Partners’s Celanese CE Stock Holding History

Waycross Partners’s Portfolio CE Stock Details CE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,400	Closed	-$1.05M	–	86
2023 Q3	$1.05M	Hold	8,400	–	–	0.23%	52
2023 Q2	$973K	Hold	8,400	–	–	0.21%	58
2023 Q1	$915K	Buy	+8,400	New	+$970K	0.27%	53
2022 Q1	–	Sell	-7,000	Closed	-$1.18M	–	80
2021 Q4	$1.18M	Buy	+7,000	New	+$1.14M	0.67%	54

Other funds holding CE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Waycross Partners's CE Position: Q4 2023 in Review

Waycross Partners sold out of Celanese (CE) in Q4 2023, closing a stake of 8,400 shares — an estimated $1.05M sold.

Waycross Partners first reported a position in CE in Q4 2021 and held it in 4 quarters. The position peaked at $1.18M in Q4 2021. 642 funds tracked by Wall St. Rank hold CE as of Q4 2023.

Waycross Partners reported no remaining Celanese position as of Q4 2023 after selling out during the quarter.
Waycross Partners sold 8,400 Celanese shares in Q4 2023, an estimated $1.05M.
Waycross Partners first reported a position in Celanese in Q4 2021 and held it in 4 quarters.
Waycross Partners's Celanese position peaked at $1.18M in Q4 2021.
642 funds tracked by Wall St. Rank held Celanese as of Q4 2023.

Based on Waycross Partners's 13F filing for Q4 2023, filed 5 Feb 2024.